CoChat

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study

Open access
Hobbs, F, Fitzmaurice, D, Mant, J, Murray, E, Jowett, S, Bryan, S, Raftery, J, Davies, M, Lip, G · 2005 · Health Technology Assessment

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF) in the population aged 65 years and over, as well as its prevalence and incidence in this age group. Also to evaluate the relative cost-effectiveness of different methods of recording and interpreting the electrocardiogram (ECG) within a screening programme. DESIGN: Multicentred randomised controlled trial. Purposefully selected general practices were randomly allocated to 25 intervention practices and 25 control practices. SETTING: Fifty primary care centres across the West Midlands, UK. PARTICIPANTS: Patients aged 65 years and over. INTERVENTIONS: GPs and practice nurses in the intervention practices received education on the importance of AF detection and ECG interpretation. Patients in the intervention practices were randomly allocated to systematic (n = 5000) or opportunistic screening (n = 5000). Prospective identification of pre-existing risk factors for AF within the screened population enabled comparison between targeted screening of people at higher risk of AF and total population screening. MAIN OUTCOME MEASURES: AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared with AF detection rate in 5000 patients in the control practices. The screening period was 12 months. RESULTS: Baseline prevalence of AF was 7.2%, with a higher prevalence in males (7.8%) and patients aged 75 years and over (10.3%). The control population demonstrated higher baseline prevalence (7.9%) than either the systematic (6.9%) or opportunistic (6.9%) intervention population. In the control population 47 new cases were detected (incidence 1.04% per year). In the opportunistic arm 243 patients without a baseline diagnosis of AF were found to have an irregular pulse, with 177 having an ECG, yielding 31 new cases (incidence 0.69% per year). A further 44 cases were detected outside the screening programme (overall incidence 1.64% per year). In the systematic arm 2357 patients had an ECG yielding 52 new cases (incidence 1.1% per year). Of these, 31 were detected by targeted screening and a further 21 by total population screening. A further 22 cases were detected outside the screening programme (overall incidence 1.62% per year). In terms of ECG interpretation, computerised decision support software (CDSS) gave a sensitivity of 87.3%, a specificity of 99.1% and a positive predictive value (PPV) of 89.5% compared with the gold standard (cardiologist reporting). GPs and practice nurses performed less well. The only difference in performance between intervention populations and controls was that practice nurses from the control arm performed less well than with intervention practice nurses on interpretation of limb-lead (PPV 38.8% versus 20.8%) and single-lead (PPV 37.7% versus 24.0%) ECGs. The within-trial economic evaluation results showed the lowest incremental cost to be for the opportunistic arm, with an incremental cost-effectiveness ratio of 337 pounds Sterling for each additional case detected compared to the control arm. Opportunistic screening dominated both more intensive screening strategies. Model-based analyses showed small differences in cost and quality-adjusted life-years for different methods and intensities of screening, but annual opportunistic screening resulted in the lowest number of ischaemic strokes and greatest proportion of cases of AF diagnosed. Probabilistic sensitivity results indicated that there was a probability of approximately 60% that screening from the age of 65 years was cost-effective in both men and women. CONCLUSIONS: The results of the study indicated that in terms of a screening programme for atrial fibrillation in patients 65 and over, the only strategy that improved on routine practice was opportunistic screening, model-based analyses indicated that there was a probability of approximately 60% of annual opportunistic screening being cost effective. It is suggested that the following topics are worthy of further investigation: the effect of the implementation of a screening programme for AF on the uptake and maintenance of anticoagulation in patients aged 65 years and over; an evaluation of the role of CDSS in the diagnosis of cardiac arrythmias; the best method for routinely detecting paroxysmal AF; ways of improving healthcare professionals' performance in ECG interpretation; development of a robust economic model to incorporate data on new therapeutic agents for use as thromboprophylactic agents for patients with AF, and an evaluation of the relative risk of stroke for patients with incident as opposed to prevalent AF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3310/hta9400

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Study CONSORT chart
FIGURE 1 Study CONSORT chartCC-BY · From the PDF
FIGURE 2 Individual sampling model
FIGURE 2 Individual sampling modelCC-BY · From the PDF
FIGURE 3 Incremental cost-effectiveness plane for annual opportunistic screening compared with no screening in men, start age 65 years
FIGURE 3 Incremental cost-effectiveness plane for annual opportunistic screening compared with no screening in men, start age 65 yearsCC-BY · From the PDF
FIGURE 4 Incremental cost-effectiveness plane for annual opportunistic screening compared with no screening in women, start age 65 years
FIGURE 4 Incremental cost-effectiveness plane for annual opportunistic screening compared with no screening in women, start age 65 yearsCC-BY · From the PDF
FIGURE 5 CEAC for annual opportunistic screening compared with no screening in men, start age 65 years
FIGURE 5 CEAC for annual opportunistic screening compared with no screening in men, start age 65 yearsCC-BY · From the PDF
FIGURE 6 CEAC for annual opportunistic screening compared with no screening in women, start age 65 years
FIGURE 6 CEAC for annual opportunistic screening compared with no screening in women, start age 65 yearsCC-BY · From the PDF
FIGURE 7 Cost-effectiveness plane: alternative opportunistic screening strategies compared with 12-lead ECG and consultant interpretation. 12L, 12-lead ECG; LL, limb-lead ECG; SL, single-lead ECG; PN, practice nurse; C, consultant.
FIGURE 7 Cost-effectiveness plane: alternative opportunistic screening strategies compared with 12-lead ECG and consultant interpretation. 12L, 12-lead ECG; LL, limb-lead ECG; SL, single-lead ECG; PN, practice nurse; C, consultant.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 16

  1. [10]10. Lake RR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med 1989;19:321-6.
  2. [11]11. Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59.
  3. [15]15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
  4. [19]19. Laupacis A, Albers G, Connolly S. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
  5. [23]23. Albers GW. Atrial fibrillation and stroke. Arch Intern Med 1994;154:1443-8.
  6. [24]24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke References Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
  7. [34]34. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomised trials. Arch Intern Med 1997;157:1237-40.
  8. [35]35. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med 1992;116:6-12.
  9. [38]38. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness analysis in medicine and health. Oxford: Oxford University Press; 1996.
  10. [41]41. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
  11. [44]44. Hobbs FDR. Should all patients with atrial fibrillation be assessed by a cardiologist? Plenary session. Proceedings from Consensus Conference on the Management of Atrial Fibrillation. Edinburgh: RCP Edinburgh; 1998.
  12. [57]57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer MD. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
  13. [60]60. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6. J Neurol Neurosurg Psychiatry 1990;53:16-22.
  14. [63]63. Office for National Statistics. Health Statistics Quarterly, 22. London: Office for National Statistics; 2004.
  15. [67]67. Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes. Journal of Health Services and Research Policy 2001;6:92-8. References
  16. [73]73. Gray JAM. Dimensions and definitions of screening. Milton Keynes: NHS Executive Anglia; Oxford: Research and Development Directorate; 1996.

Cited by

Items 301–400 of 437

Metadata

Authors
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G.
Affiliations
  • University of Birmingham (GB)
  • Selly Oak Hospital (GB)
  • Birmingham City Hospital (GB)
Venue
Health Technology Assessment
Published
2005-10
Volume
9
Issue
40
Pages
iii-iv, ix
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
OpenAlex
W2018796325
Cited by
437
References
60
Citations by year
2026: 13 · 2025: 25 · 2024: 24 · 2023: 17 · 2022: 32 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 34 · 2017: 25 · 2016: 31 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 18
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • Apollo
Funders
Health Technology Assessment programme (96/22/11)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
atrial fibrillation, systematic screening, opportunistic screening, targeted screening, cost-effectiveness, ECG interpretation, irregular pulse, atrial fibrillation prevalence, atrial fibrillation incidence, older adults, primary care, atrial fibrillation risk factors, practice nurses, general practitioners, atrial fibrillation mortality
MeSH terms
Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, United Kingdom, Humans, Male, Mass Screening, Primary Health Care, Risk Factors, Incidence, Prevalence, Outcome Assessment, Health Care, Sample Size

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.